XRP Healthcare has announced its entry into the evolving Africa’s healthcare market through the acquisition of Pharma Ville, a leading Ugandan pharmacy chain.
With two retail pharmacies and five wholesale distribution centres across Uganda, Pharma Ville has established itself by enhancing medicine accessibility nationwide.
Officials said the acquisition strengthens XRP Healthcare’s ability to streamline pharmaceutical supply chains and expand its footprint in Africa’s healthcare market.
Pharma Ville works with the National Medical Stores (NMS) and Joint Medical Stores (JMS) to ensure a steady and reliable supply of essential medicines.
The acquisition includes 60 registered pharmaceutical products, 18 products ready for immediate commercialization, and 70 additional products in the pipeline awaiting regulatory approval.
Pharma Ville has distribution agreements with eight global pharmaceutical suppliers including Toros Group (Switzerland) for orthopedic supplies, Ascensia Switzerland (Germany) for diabetic care solutions, Incepta Pharmaceuticals Ltd (Bangladesh) for human drugs, Amanta Health Care Limited (India) for intravenous fluids and Forans Latvia (Latvia) for diabetic care products, Mediteks (Turkey) for surgical equipment, Naari Pharma Pvt Limited (India) for human drugs and Universal Corporation Limited (Kenya) for human drugs , reinforcing its strong supply chain network.
Richard Kitonsa (MPS), Founder and CEO of Pharma Ville, emphasized the transformative impact of the acquisition.
“Joining XRP Healthcare is transformative. We can now rapidly scale our operations, introduce innovative technologies, and better serve Uganda’s healthcare needs.”
Whitney Lynn, Chairman of XRP Healthcare, underscored the company’s mission, saying, “ Our goal is simple—make essential medicines more accessible and affordable. This acquisition is a major step toward achieving that.”
Kain Roomes, CEO of XRP Healthcare, highlighted the opportunity within Uganda’s healthcare sector:
“Uganda’s fragmented pharmaceutical landscape presents immense potential. By integrating Pharma Ville, we can deliver immediate impact—improving access to essential medicines and optimizing healthcare delivery.”
Laban Roomes, COO of XRP Healthcare, emphasized the groundwork laid for expansion:
“We have spent significant time in Uganda developing the legal and operational frameworks necessary to scale this business rapidly. Our efforts will drive long-term improvements in healthcare accessibility.”
By the fourth quarter, Pharma Ville will rebrand as XRP Healthcare, aligning with the company’s vision for innovation and healthcare excellence.
Peter Waiswa, a strategic advisor to UNICEF, the Bill & Melinda Gates Foundation, and now XRP Healthcare, praised the acquisition’s significance.
“This acquisition strengthens Uganda’s healthcare sector, fosters economic growth, and introduces essential technologies to the industry. It’s a major step forward for healthcare accessibility in Uganda.”
With Africa’s healthcare market projected to reach $259 billion by 2030, and the digital health segment—encompassing AI-driven solutions—expected to grow to $16.6 billion, XRP Healthcare is strategically positioned to capitalize on these transformative opportunities.
XRP Healthcare holds registered trademarks in Uganda, the UAE, and the UK, with ongoing global registrations, reinforcing its commitment to innovation and brand excellence.
